当前位置：
X-MOL 学术
›
Eur. J. Nucl. Med. Mol. Imaging
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum
European Journal of Nuclear Medicine and Molecular Imaging ( IF 9.1 ) Pub Date : 2024-03-07 , DOI: 10.1007/s00259-024-06641-w Julia Fricke , Frida Westerbergh , Lisa McDougall , Chiara Favaretto , Emanuel Christ , Guillaume P. Nicolas , Susanne Geistlich , Francesca Borgna , Melpomeni Fani , Peter Bernhardt , Nicholas P. van der Meulen , Cristina Müller , Roger Schibli , Damian Wild
中文翻译：
首次在回肠转移性神经内分泌肿瘤患者中给予铽 161 标记的生长抑素受体亚型 2 拮抗剂 ([161Tb]Tb-DOTA-LM3)
更新日期：2024-03-07
European Journal of Nuclear Medicine and Molecular Imaging ( IF 9.1 ) Pub Date : 2024-03-07 , DOI: 10.1007/s00259-024-06641-w Julia Fricke , Frida Westerbergh , Lisa McDougall , Chiara Favaretto , Emanuel Christ , Guillaume P. Nicolas , Susanne Geistlich , Francesca Borgna , Melpomeni Fani , Peter Bernhardt , Nicholas P. van der Meulen , Cristina Müller , Roger Schibli , Damian Wild
|
中文翻译：
首次在回肠转移性神经内分泌肿瘤患者中给予铽 161 标记的生长抑素受体亚型 2 拮抗剂 ([161Tb]Tb-DOTA-LM3)
京公网安备 11010802027423号